Leveraging extensive experience in protein therapeutics toward the development of our partners’ biologics.

The Pelican Expression Technology™ platform is unique in its ability to express complex antibody derivatives and other engineered binding modalities. These complex modalities have the potential for greater specificity, improved side effect profiles and ultimately successful therapeutic outcomes making them the focus of current biopharmaceutical development.

Pelican Expression Technology Platform Overview

Prior Successes

The Pelican Expression Technology platform has demonstrated its versatility through the successful production of a broad range of natural and engineered proteins. We are leveraging that success to create value for our partners.

Intellectual Property

Ligand maintains a broad and comprehensive platform and product intellectual property portfolio with 27 U.S. issued patents as of December 2020 and additional in various stages of prosecution.